SAB Biotherapeutics Inc.

NASDAQ: SABS · Real-Time Price · USD
2.86
0.28 (10.85%)
At close: Sep 18, 2025, 3:59 PM
2.90
1.40%
Pre-market: Sep 19, 2025, 05:01 AM EDT
10.85%
Bid 2.58
Market Cap 29.78M
Revenue (ttm) -410
Net Income (ttm) -37.06M
EPS (ttm) -3.99
PE Ratio (ttm) -0.72
Forward PE -2.21
Analyst Buy
Dividends n/a
Ask 3
Volume 760,048
Avg. Volume (20D) 1,474,127
Open 2.60
Previous Close 2.58
Day's Range 2.54 - 2.92
52-Week Range 1.00 - 6.60
Beta 0.55
Ex-Dividend Date n/a

About SABS

undefined

Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol SABS
Website n/a
Full Company Profile

Analyst Forecast

According to 0 analyst ratings, the average rating for SABS stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

Stock Forecasts
SAB Biotherapeutics Inc. is scheduled to release its earnings on Nov 5, 2025, after market closes.
Analysts project revenue of ... Unlock content with Pro Subscription
2 days ago
+20%
SAB Biotherapeutics shares are trading higher. Lee... Unlock content with Pro Subscription
1 month ago
-3.33%
SAB Biotherapeutics shares are trading lower after HC Wainwright & Co. cut its price target on the stock from $10 to $9.